Vimarsana
Biggest News Aggregation in the World

Page 27 - David Clair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Clair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Clair Today - Breaking & Trending Today

Bio-Techne Releases First Quarter Fiscal 2022 Results - Vimarsana News

Bio-Techne Releases First Quarter Fiscal 2022 Results

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021. First Quarter FY2022...

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS - Form 8-K - Vimarsana News

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS - Form 8-K

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS Minneapolis/November 2, 2021/ Bio-Techne Corporation today reported its financial results for the first quarter ended... | November 2, 2021

Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript - Vimarsana News

Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript

TECH earnings call for the period ending September 30, 2021.

Source: fool.com
Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases - Vimarsana News

Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in...

Bio Techne : To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results - Vimarsana News

Bio Techne : To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results

MINNEAPOLIS, Oct. 11, 2021 /PRNewswire/ -- Bio-Techne Corporation today announced that management will host a conference call and webcast on Tuesday, November 2, 2021, at 8:00 a.m. CDT to review... | October 11, 2021